EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A nuclear delivery strategy for curative treatment of COPD using 1α,25-dihydroxyvitamin D3 and lipid nanoparticles

Tomomi Akita, Wakana Nemoto, Takehiro Kawai, Chikamasa Yamashita

The Journal of Steroid Biochemistry and Molecular Biology · 2026-09 · 262 · 107045

DOI: 10.1016/j.jsbmb.2026.107045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2026-09. Verfasst von Tomomi Akita und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, 2641 Yamazaki, Noda, Chiba 278-8510, Japan. Electronic address: ak…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Nanoparticles, Calcitriol, Lipids. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) presents with obstructive ventilation disorders. Because no drugs can regenerate destroyed alveoli, there is an urgent need for new treatments that repair alveolar damage. We previously reported revealed that 1α,25-dihydroxyvitamin D3 (1,25(OH) 2 D 3 ) showed emphysema-improving effects in COPD model mice. However, because 1,25(OH) 2 D 3 carries a risk of serious adverse effects such as hypercalcemia, strategies to reduce the risk are needed to allow further dose reduction. To solve this problem and achieve efficient intracellular drug delivery, we focused on SS-cleavable proton-activated lipid-like material O-Phentyl-P4C2 (COATSOME Ⓡ SS-OP; hereafter "SS-OP") and helper lipid as the components of lipid nanoparticles. In this study, we investigated intracellular drug delivery, emphysema-improving effect, and reduction of adverse effect risk by 1,25(OH) 2 D 3 -encapsulated SS-OP lipid nanoparticle (SLPs) prepared using either of two helper lipids: 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). Only 1,25(OH) 2 D 3 -encapsulated SLPs prepared using DOPE achieved efficient drug delivery, increased nuclear translocation relative to Free 1,25(OH) 2 D 3 , and successfully induced lung cell differentiation and improvement of the respiratory function at a lower dose. Moreover, the use of DOPE-based 1,25(OH) 2 D 3 -encapsulated SLPs, reduced elevated serum Ca 2+ levels, and these formulations are expected to be a therapeutic candidate for COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveNanoparticlesCalcitriolLipidsDrug Delivery SystemsVitamin DAnimalsHumansMiceCell NucleusLiposomes

Stichwörter der Autor:innen

1α25-dihydroxyvitamin D3Chronic obstructive pulmonary diseaseLipid nanoparticlePulmonary administrationSerum Ca(2+) concentration

Substanzen

CalcitriolLipidsVitamin DLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, 2641 Yamazaki, Noda, Chiba 278-8510, Japan. Electronic address: akitat@rs.tus.ac.jp.
  • Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
  • Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, 2641 Yamazaki, Noda, Chiba 278-8510, Japan. Electronic address: chikamasa_yamashita@rs.tus.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Akita, T., Nemoto, W., Kawai, T., & Yamashita, C. (2026). A nuclear delivery strategy for curative treatment of COPD using 1α,25-dihydroxyvitamin D3 and lipid nanoparticles. The Journal of Steroid Biochemistry and Molecular Biology, 262, 107045. https://doi.org/10.1016/j.jsbmb.2026.107045

Vancouver

Akita T, Nemoto W, Kawai T, Yamashita C. A nuclear delivery strategy for curative treatment of COPD using 1α,25-dihydroxyvitamin D3 and lipid nanoparticles. The Journal of Steroid Biochemistry and Molecular Biology. 2026;262:107045. doi:10.1016/j.jsbmb.2026.107045

BibTeX
@article{Akita2026,
  author = {Akita, Tomomi and Nemoto, Wakana and Kawai, Takehiro and Yamashita, Chikamasa},
  title = {A nuclear delivery strategy for curative treatment of COPD using 1α,25-dihydroxyvitamin D3 and lipid nanoparticles},
  journal = {The Journal of Steroid Biochemistry and Molecular Biology},
  year = {2026},
  volume = {262},
  pages = {107045},
  doi = {10.1016/j.jsbmb.2026.107045}
}
Kostenlos starten →